Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle device with rapamycin and epigallocatechin gallate effectively promoted hair regrowth in mice.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Topical finasteride might be a good alternative for hair loss treatment with fewer side effects, but more research is needed.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

Geriatric Julia Creek dunnarts often suffer from reproductive and skin diseases, impacting conservation efforts.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Hair loss can be an early sign of prostate enlargement.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Somatostatin may help protect hair follicles from immune attacks.

Dutasteride reduces DHT more effectively than finasteride.

The Foxn1(-/-) nude mouse shows disrupted and expanded skin stem cell areas due to high Lhx2 levels.

Researchers created a long-lasting mouse skin cell strain that may help with hair growth research and treatments.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Ostrich antibodies can help restore hair growth in people with a specific type of hair loss, increasing hair count by 71% on average.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Mouse models help understand alopecia areata and find treatments.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Ultra-high molecular weight poly-γ-glutamic acid may help promote hair growth.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Women with congenital adrenal hyperplasia showed no prostatic growth.